Advertise At Life Technology™ And Your Ad Will Be Displayed On All 100,000+ Pages Of www.lifetechnology.com.

[Index] [Latest News] [Latest Medical News] [Latest Science News] [Latest Technology News] [RSS Feeds]



Oncology & Cancer -

Skipping adjuvant radiotherapy may not impact risk of recurrence or progression in patients with low-risk DCIS RSS



Skipping Adjuvant Radiotherapy in Low-Risk DCIS Patients

Skipping Adjuvant Radiotherapy may not Impact Risk of Recurrence or Progression in Patients with Low-Risk DCIS

Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer where abnormal cells are found in the lining of the breast ducts. It is considered a low-risk condition, as the abnormal cells have not spread beyond the ducts into the surrounding breast tissue. Adjuvant radiotherapy is a common treatment option for patients with DCIS, but recent studies suggest that skipping this treatment may not significantly impact the risk of recurrence or progression in low-risk DCIS patients.

A study published in the Journal of the American Medical Association (JAMA) in 2015 examined the outcomes of over 3,000 women with low-risk DCIS who underwent breast-conserving surgery (lumpectomy) without adjuvant radiotherapy. The study found that the 10-year risk of local recurrence was 8.7% for patients who did not receive radiotherapy, compared to 8.8% for those who did receive radiotherapy. These results indicate that skipping adjuvant radiotherapy did not significantly increase the risk of recurrence in low-risk DCIS patients.

Another study published in the New England Journal of Medicine in 2018 further supported these findings. The study included over 1,300 women with low-risk DCIS who underwent breast-conserving surgery without adjuvant radiotherapy. The 10-year risk of local recurrence was 12.3% for patients who did not receive radiotherapy, compared to 14.7% for those who did receive radiotherapy. Although there was a slightly higher risk of recurrence in the group that skipped radiotherapy, the difference was not statistically significant.

These studies suggest that adjuvant radiotherapy may not be necessary for all low-risk DCIS patients. However, it is important to note that these findings apply specifically to patients with low-risk DCIS, and individual cases may vary. Factors such as age, tumor size, grade, and hormone receptor status should be taken into consideration when determining the appropriate treatment plan for each patient.

It is also worth mentioning that adjuvant radiotherapy can have side effects, including skin changes, fatigue, and long-term effects on breast appearance. By avoiding radiotherapy, patients may be able to avoid these potential side effects and maintain a better quality of life.

It is crucial for patients with low-risk DCIS to have a thorough discussion with their healthcare provider to weigh the potential benefits and risks of adjuvant radiotherapy. Shared decision-making between the patient and healthcare provider is essential in determining the most appropriate treatment plan for each individual.

In conclusion, recent studies suggest that skipping adjuvant radiotherapy may not significantly impact the risk of recurrence or progression in patients with low-risk DCIS. However, individual cases may vary, and a thorough discussion with a healthcare provider is necessary to determine the most appropriate treatment plan for each patient.


[Sponsor This Article] or [Sponsor All 100,000+ Articles At Life Technology™ Via A Corporate Sponsorship]
Life Technology™ is an Approved Google News Publisher and utilizes [ConvergenceX™], our omniscient and superluminally fast artificial intelligence, predictive analytics, and quantum logic algorithms powered news article publishing and news headlines aggregation engine, to curate, write, SEO optimize, and publish over 10,000 original news articles, and aggregate over 1,000,000 news article headlines per month. [ConvergenceX™] derived news articles and feeds are now available for commercial or non commercial use via [Syndication].

© Article Copyright 1999-2024 [Life Technology™] Via [ConvergenceX™] [Advertise] [Publish] [Syndication]
Advertise At Life Technology™ And Your Ad Will Be Displayed On All 100,000+ Pages Of www.lifetechnology.com.

To advertise here and on all 100,000+ pages of www.lifetechnology.com visit [Advertise At Life Technology™]. To guest post / publish an article at Life Technology™ visit [Publish An Article At Life Technology™]. To guest post / publish an article at Life Technology™ and Google News visit [Publish An Article At Life Technology™ And Google News]. For our article writing service visit [Life Technology™ Article Writing Service].

To sponsor an article at Life Technology™ visit [Sponsor An Article At Life Technology™]. For corporate sponsorship at Life Technology™ visit [Corporate Sponsorship At Life Technology™].

To republish the content of this or any other article from Life Technology™ for non commercial purposes visit [Copyright And Royalty Free RSS Feeds For Commercial And Non Commercial Use]. To republish the content of this or any other article from Life Technology™ for commercial purposes visit [Syndication].

Since 1999 Life Technology™ has published news content entirely free of charge. Because we do not charge a subscription fee we would kindly request that you [Make A Donation To Life Technology™] and please, do share this article with your coworkers, friends, family and favorite social media platform. For any and all other enquiries please [contact] us.


Advertise At Life Technology™ And Your Ad Will Be Displayed On All 100,000+ Pages Of www.lifetechnology.com.
  • Advertise At Life Technology™ And Your Ad Will Be Displayed On All 100,000+ Pages of www.lifetechnology.com
  • Research finds genetic variation that could lead to increased risk of viral infections
  • Navy Growler jet noise over Washington state's Whidbey Island could impact 74,000 people's health
  • Predicting and detecting abuse in supported living for people with a learning disability and autistic people
  • Bullying significant issue for young people in aftermath of eye cancer, study shows
  • Australian study finds large support for blocking online alcohol content
  • Low-cost MRI paired with AI produces high-quality results
  • Older Singaporeans who volunteer perceive a better quality of life, finds study
  • Patients with chronic lung disease who live farther from a hospital found to have poorer survival rate
  • Human brain map contains never-before-seen details of structure
  • Bariatric surgery tied to higher short-term risk for venous thromboembolism
  • What makes a public health campaign successful?
  • Symptom burden prevalent in childhood cancer survivors
  • Adoption study links child behavior issues with mother's trauma
  • Thrombectomy linked to better outcomes for acute stroke, large infarct
  • Researchers identify highly drug-resistant infections from stem cell treatments in Mexico
  • Growing body of research shows importance of addressing loneliness, social isolation
  • Q&A: Study details how major advances have been implemented in intensive diabetes management
  • Collaboration uncovers an entirely new COVID-related syndrome
  • Study reveals how gender affects liver transplant success in cancer patients
  • How ultrasound and microbubbles could deliver immunotherapy to the brain
  • Unraveling the link between the microbiome and esophageal cancer
  • Q&A: Do you know your risks for breast cancer?
  • High school student helps transform 'crazy idea' into a model that can predict neurotransmitters
  • Keto diet boosts lifesaving antifungal drug in mice
  • Scope of maternal substance use disorder crisis is dramatically underestimated, says study
  • Call the midwife: Study highlights maternity care model's success
  • New stem cell research may have implications for liver transplantation
  • Researchers discover benefits of adding immune-boosting agent to personalized cancer vaccine
  • Some brain tumors may be linked to head injury, mouse study suggests
  • Paris in spring, Bali in winter: How 'bucket lists' help cancer patients handle life and death
  • Study finds patients with limited English proficiency have poorer experiences with virtual health care
  • AI advancements make the leap into 3D pathology possible
  • Scientists pinpoint new vaccine adjuvant that promotes potent anti-tumor immunity
  • New cells could be key to treating obesity
  • Study shows not all ultra-processed foods are bad for your health
  • Researchers estimate vaccines have saved 154 million lives over past half-century
  • Telehealth group sessions can benefit clinician-patient relationships
  • Scientists discover how deadly skin cancer evades the human immune system
  • Researchers investigate the relationship between perceived glossiness and pupillary responses
  • Cancer: Here's the role exercise plays, from prevention to treatment
  • Arizona's now-repealed abortion ban serves as a cautionary tale for reproductive health care across the US
  • AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher says
  • Brain study identifies a cost of caregiving for new fathers
  • Study shows that astrocytes integrate information about past events in their soma
  • Study identifies primary cause of sensory hypersensitivity in a mouse model of autism spectrum disorder
  • Caribbean researchers innovate to protect cancer patients from compounding disasters
  • Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival: Study
  • Study introduces hyperspectral dark-field microscopy for rapid and accurate identification of cancerous tissues
  • New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
  • Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapy

  • [Subscribe] To [Life Technology™ Medical News] Via [Feedburner] [Google News] [RSS] Or Search [Tags]

    [Subscribe] To [Life Technology™ Science News] Via [Feedburner] [Google News] [RSS] Or Search [Tags]

    [Subscribe] To [Life Technology™ Technology News] Via [Feedburner] [Google News] [RSS] Or Search [Tags]



    [Index] [Top] [Business] [Entertainment] [Health] [Nation] [Science] [Sports] [Technology] [World]


    Advertise At Life Technology™ And Your Ad Will Be Displayed On All 100,000+ Pages Of www.lifetechnology.com.